Archer Materials Limited · ASX:AXE
Archer Materials — Investor Presentation (February 2020)
25 slides from Archer Materials's investor presentation, Feb 10, 2020
Slide 1: Understanding Graphene: The world's thinnest material and its use in biotech
/ Company Presentation For personal use only Understanding Graphene: The world’s thinnest material and its use in biotech February 2020
Slide 2: Disclaimer
/ Disclaimer The material contained in this document is a presentation of general information about the activities of Archer and its related bodies For personal use only corporate (together the “Archer Group”), current as at the date of this presentation. It is provided in summary and does not purpo
Slide 3: Company Snapshot
/ Company Snapshot For personal use only Archer Materials Limited ASX: AXE 3
Slide 4: Board and Executive Management
/ Board and Executive Management For personal use only 4
Slide 5: Capital Structure & Overview
/ Capital Structure & Overview $2.7m 212.4m For personal use only Cash in bank as of 31 Dec 2019 Number of ordinary shares on issue $0.22 $46.7m Share price (7 Feb 2020) Market capitalisation (7 Feb 2020) 27% Of issued shares held by top 20 7% Of issued shares held by Archer’s shareholders Board and
Slide 6: Archer provides shareholders exposure to innovative technologies and materials
Archer provides shareholders exposure to financial returns from innovative technologies For personal use only and the materials that underpin them Our strategy is to build an industry-leading Materials Technology company, that delivers maximum value to our shareholders through the commercialisation
Slide 7: The acquisition of Carbon Allotropes enabled Archer to expand its market position
The acquisition of Carbon Allotropes enabled Archer to expand its market For personal use only position Archer’s growth involves contributing to complex global challenges. Archer is uniquely positioning to meet global markets’ needs through several key strengths: + Strong, globally filed patents pro
Slide 8: Significant Developments in 2019-2020
/ Significant Developments in 2019-2020 For personal use only Human Quantum Reliable Health Technology Energy + High quality graphene inks prepared + Archer obtains exclusive licence to + Full-cell Li-ion batteries produced and tested for printed biosensing quantum technology IP (QTIP) with Campoona
Slide 9: Advanced Materials
/ Advanced Materials For personal use only Materials are the tangible basis of all technology. 9
Slide 10: Materials Discovery
/ Materials Discovery For personal use only 10
Slide 11: Graphene Materials
/ Graphene Materials For personal use only A single carbon layer of the graphite structure, describing its nature by analogy to a polycyclic aromatic hydrocarbon of quasi infinite size1. + Graphene has a combination of exceptional materials’ properties that could make it useful and valuable2. + Arch
Slide 12: Value from the Atom Scale
/ Value from the Atom Scale For personal use only Archer is developing graphene-based technology by applying unique materials discovery schemes focused on commercially exploiting graphene at the atom-scale for potential high-value end uses, including in biosensors. + Graphene can only physically exi
Slide 13: Human Health: Printable graphene biosensors
/ Human Health For personal use only Printable graphene biosensors 13
Slide 14: Biosensors for In-vitro Diagnostics
/ Biosensors for In-vitro Diagnostics For personal use only *More information on Australian regulations related to IVDs: https://www.tga.gov.au/medical-devices-ivds 14
Slide 15: Successful commercialisation of biosensor technology could disrupt a global industry
Successful commercialisation of Archer’s biosensor technology could disrupt a global multibillion dollar industry For personal use only $27b Forecast size of biosensor 43.5% Cash refund of annual R&D industry in 20228 spend in Australia for SMEs9 $20b 140+ Australian industry spend Life sciences com
Slide 16: Successful development of printable biosensor could enable rapid multi-disease detection
Archer’s graphene-based ink materials. Successful development of Archer’s printable biosensor could enable rapid & For personal use only customised multi-disease detection 1 World-first graphene biosensor materials Archer is using the only reported graphene materials capable of stable and robust sel
Slide 17: Commercial Pathway
Archer affiliates preparing chemical adducts & precursors to materials’ syntheses at UNSW. / Commercial Pathway For personal use only 17
Slide 18: Commercialisation pathway applying the triple-helix business model
Archer’s first-version biosensor platform built at the ARC Graphene Hub (Aug 2019). The commercialisation pathway involves applying the triple-helix business model+ For personal use only for biotechnology innovation Our strategy is to develop printable graphene-based biosensor componentry and sublic
Slide 19: Graphene Impact on Biotechnology
/ Graphene Impact on Biotechnology For personal use only ^ Nature Commun., 9, 1577 (2018) *Nature Biomed. Eng., 3, 427–437 (2019) #npj Clean Water, 1, 5 (2018) **Nature Nanotech., 11, 127–136 (2016) ***Int. J. Nanomedicine, 14, 5753–5783 (2019) ^^Sci. Rep., 9, 19311 (2019) 19
Slide 20: Strategic Direction: The Path Forward
/ Strategic Direction For personal use only The Path Forward 20
Slide 21: Company News Flow
/ Company News Flow Over the next 12 months key aspects of our strategy to provide For personal use only shareholder returns include: + Patenting & developing graphene biosensors Patent Cooperation Treaty application decision point, and development milestones in building proof-of-concept devices. +
Slide 22: Archer Materials contact details
The Board of Archer authorised this announcement to be given to ASX. For personal use only Archer Materials Limited ASX Code: AXE ACN: 123 993 233 ADELAIDE SYDNEY Ground Floor, 28 Greenhill Road Level 4, 17-19 Bridge Street Wayville SA 5034 Australia Sydney NSW 2000 Australia Phone: +61 8 8272 3288
Slide 23: Appendices: Board and Executive Management
Appendices For personal use only Board and Executive Management (Slide 4) Greg English LLB, BE (Mining) Greg English is the co-founder Archer. He has been Chairman of the board since 2008 and has overseen Executive Chairman Archer’s transition from a South Australian focussed minerals exploration co
Slide 24: Appendices: Board and Executive Management
Appendices For personal use only Board and Executive Management (Slide 4) Mohammad Choucair PhD, FRACI FRSN GAICD Dr Mohammad Choucair was appointed Chief Executive Officer on 1st December 2017. Dr Choucair has Chief Executive Officer a strong technical background in nanotechnology, and has spent th
Slide 25: Appendices: Technology and Commercial Readiness Levels
Appendices For personal use only Reference to Technology Readiness Level (“TRL”) and Commercial Readiness Level (“CRL”) on Slide 17. 25
Archer Materials — Investor Presentation (February 2020) on 6ix